Maynards is auctioning modern clinical stage biopharmaceutical equipment – including flow cytometers, microplate readers and sequencers – formerly operated by Achilles Therapeutics. The assets come to the market due to operational restructuring of the company. The auction takes place in partnership with Heritage Global Partners. Biopharmaceutical firm Achilles Therapeutics develops T cell therapies for the treatment of solid tumour cancers.
The online auction opens on the 26th of January and bidding closes on the 12th of February. Over 600 lots feature in the auction, including: Heraus Megafuge centrifuge, Liebherr LKUexv 1610 lab fridge, Liebherr LGUexv 1500 lab freezer, Heraus HeraSafe 2030i 1.2 laminar flow cabinets (2020), (2) Phcbi MCO-170AICUVO CO2 incubator (2018), (2) Phcbi MCO-170AICUVO CO2 incubator (2018), Eppendorf 5427 R centrifuge, Thermo Fisher Multifuge X4R Pro centrifuge (2020), Thermo Fisher Multifuge X3R centrifuge (2017), Agilent BioTek Synergy H1 microplate reader (2023), Bio-Techne ProteinSimple Ella automated ELISA platform (2021), (2) StarLab Mixer HC thermomixer, Logos Biosystem Luna-FL fluorescence cell counter, Micronic DR 505 rack reader, Olympus CKX53 microscope and much, much more. The assets are located in London, Stevenage, UK and Philadelphia. Equipment can be viewed by appointment with the auctioneer only.
Global auctioneering firm Maynards was established in Vancouver in 1902. Maynards has global reach through their offices in the United States, Canada, Germany, England, Japan and China and provides liquidation and valuation services to a broad range of industry sectors.
For further information about this, or any other Maynards auction, please visit: